FANCF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.380100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.373200E-01
Normal-vs-Stage2
4.875800E-02
Normal-vs-Stage3
2.657800E-02
Normal-vs-Stage4
6.837000E-01
Stage1-vs-Stage2
3.135200E-01
Stage1-vs-Stage3
1.159780E-02
Stage1-vs-Stage4
8.576000E-01
Stage2-vs-Stage3
5.566200E-02
Stage2-vs-Stage4
5.726600E-01
Stage3-vs-Stage4
1.738360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.619600E-02
Normal-vs-AfricanAmerican
6.289800E-02
Normal-vs-Asian
3.819200E-01
Caucasian-vs-AfricanAmerican
8.493800E-01
Caucasian-vs-Asian
5.855000E-01
AfricanAmerican-vs-Asian
5.255200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.230400E-02
Normal-vs-Female
8.355800E-02
Male-vs-Female
5.674000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.735030E-01
Normal-vs-Age(41-60Yrs)
8.075500E-02
Normal-vs-Age(61-80Yrs)
5.753700E-02
Normal-vs-Age(81-100Yrs)
6.724300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.887200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.118200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.418600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.792780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.568200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.565700E-02
Normal-vs-Daily Drinker
7.969600E-02
Normal-vs-Weekly Drinker
2.282300E-02
Normal-vs-Occasional Drinker
2.672000E-01
Normal-vs-Social Drinker
1.850050E-01
Non Drinker-vs-Daily Drinker
8.858000E-01
Non Drinker-vs-Weekly Drinker
1.500840E-01
Non Drinker-vs-Occasional Drinker
1.094800E-01
Non Drinker-vs-Social Drinker
3.483000E-01
Daily Drinker-vs-Weekly Drinker
1.478980E-01
Daily Drinker-vs-Occasional Drinker
1.742790E-01
Daily Drinker-vs-Social Drinker
4.515200E-01
Weekly Drinker-vs-Occasional Drinker
1.196100E-02
Weekly Drinker-vs-Social Drinker
5.044000E-02
Occasional Drinker-vs-Social Drinker
6.038000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.244400E-03
Normal-vs-Grade 2
1.317670E-03
Normal-vs-Grade 3
1.178920E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.154400E-01
Grade 1-vs-Grade 3
6.590000E-01
Grade 1-vs-Grade 4
6.244400E-03
Grade 2-vs-Grade 3
6.381400E-01
Grade 2-vs-Grade 4
1.317670E-03
Grade 3-vs-Grade 4
1.178920E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.245800E-02
Normal-vs-NonDiabetic
7.894000E-02
Diabetic-vs-NonDiabetic
5.570000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.621900E-02
Normal-vs-NoPancreatitis
6.510300E-02
Pancreatitis-vs-NoPancreatitis
6.522600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.336300E-02
Normal-vs-N1
5.560400E-02
N0-vs-N1
6.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.457400E-01
Normal-vs-TP53-NonMutant
2.625600E-01
TP53-Mutant-vs-TP53-NonMutant
5.175000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
